Vicor Total Cost of Revenue increased by 5.8% to $50.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.0%, from $49.60M to $50.60M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 1.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.51M | $42.10M | $49.47M | $50.68M | $55.34M | $56.15M | $56.35M | $51.28M | $51.57M | $51.97M | $45.31M | $38.75M | $43.08M | $47.42M | $45.81M | $49.60M | $48.92M | $46.91M | $47.84M | $50.60M |
| QoQ Change | — | -7.5% | +17.5% | +2.5% | +9.2% | +1.5% | +0.4% | -9.0% | +0.6% | +0.8% | -12.8% | -14.5% | +11.2% | +10.1% | -3.4% | +8.3% | -1.4% | -4.1% | +2.0% | +5.8% |
| YoY Change | — | — | — | — | +21.6% | +33.4% | +13.9% | +1.2% | -6.8% | -7.4% | -19.6% | -24.4% | -16.5% | -8.7% | +1.1% | +28.0% | +13.5% | -1.1% | +4.4% | +2.0% |